AORT Artivion, Inc.
Healthcare$23.19+3.25%ClosedMarket Cap: $1.13B
As of 2026-05-26
Valuation
P/E (TTM)
184.47
PEG
1.07
P/B
2.40
P/S
2.38
EV/EBITDA
20.87
DCF Value
$-1.97
FCF Yield
1.2%
Div Yield
0.0%
Margins & Returns
Gross Margin
62.9%
Operating Margin
7.8%
Net Margin
2.5%
ROE
2.7%
ROA
1.3%
ROIC
3.0%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $116.3M | 61.5% | $7.5M | $1.4M | $— | — |
| Q4 null | $116.0M | 60.1% | $7.2M | $2.4M | $— | — |
| FY null | $441.3M | 61.3% | $26.7M | $9.8M | $— | — |
| Q3 null | $113.4M | 65.6% | $12.5M | $6.5M | $— | — |
| Q2 null | $113.0M | 64.7% | $8.4M | $1.3M | $— | — |
| Q1 null | $99.0M | 64.2% | $2.1M | $-505.0K | $— | — |
| Q4 null | $97.3M | 63.2% | $2.7M | $-16.5M | $— | — |
| FY null | $388.5M | 64.0% | $38.9M | $-13.4M | $— | — |
| Q3 null | $95.8M | 63.7% | $4.4M | $-2.3M | $— | — |
| Q2 null | $98.0M | 64.6% | $6.5M | $-2.1M | $— | — |
| Q1 null | $97.4M | 64.6% | $25.3M | $7.5M | $— | — |
| Q4 2023 | $93.7M | 65.2% | $3.2M | $-4.0M | $-0.10 | — |